Pacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Pacific Bio (PACB) Tops Q2 EPS by 1c
August 4, 2016 4:11 PM EDTPacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $20.19 million.
For earnings history and earnings-related data on Pacific Bio (PACB) click here.
... More